Cambridge Investment Research Advisors’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,123
| Closed | -$198K | – | 3628 |
|
|
2025
Q1 | $198K | Sell |
10,123
-455
| -4% | -$8.9K | ﹤0.01% | 3215 |
|
|
2024
Q4 | $262K | Buy |
10,578
+143
| +1% | +$3.54K | ﹤0.01% | 2950 |
|
|
2024
Q3 | $256K | Buy |
+10,435
| New | +$256K | ﹤0.01% | 2946 |
|
|
2023
Q1 | – | Sell |
-5,658
| Closed | -$221K | – | 3162 |
|
|
2022
Q4 | $221K | Buy |
5,658
+197
| +4% | +$7.7K | ﹤0.01% | 2669 |
|
|
2022
Q3 | $260K | Buy |
+5,461
| New | +$260K | ﹤0.01% | 2484 |
|
|
2022
Q1 | – | Sell |
-2,616
| Closed | -$208K | – | 3168 |
|
|
2021
Q4 | $208K | Sell |
2,616
-867
| -25% | -$68.9K | ﹤0.01% | 2861 |
|
|
2021
Q3 | $303K | Sell |
3,483
-4,136
| -54% | -$360K | ﹤0.01% | 2458 |
|
|
2021
Q2 | $981K | Buy |
7,619
+4,306
| +130% | +$554K | ﹤0.01% | 1548 |
|
|
2021
Q1 | $265K | Sell |
3,313
-513
| -13% | -$41K | ﹤0.01% | 2373 |
|
|
2020
Q4 | $312K | Buy |
+3,826
| New | +$312K | ﹤0.01% | 2101 |
|